| Literature DB >> 26573051 |
Shadieh Abdollahi1, Rashid Ramazanzadeh, Zahra Delami Khiabani, Enayat Kalantar.
Abstract
BACKGROUND &Entities:
Mesh:
Substances:
Year: 2015 PMID: 26573051 PMCID: PMC4873572 DOI: 10.5539/gjhs.v8n4p109
Source DB: PubMed Journal: Glob J Health Sci ISSN: 1916-9736
Primers used in Multiplex PCR (Matthew, Sullivan, Cai, Kong, Zeng, & Gilbert, 2006)
| Gene | Primer: sequence | Size |
|---|---|---|
| ermA/TRSb: 5’ TCA GGA AAA GGA CAT TTT ACC3’ | ||
| ermAAb: 3’ATA TAG TGG TGG TAC TTT TTT GAG C5’ | ||
| ermBAb: 5’CGA TAT TCT CGA TTG ACC C3’ | ||
| ermBSb: 3’GGT AAA GGG CAT TTA ACG AC5’ | ||
| ermCab: 5’ TAGCAAACCCGTATTCCACG3’ | ||
| ermCsb: 3’CTTGTTGATCACGATAATTTCC5’ | ||
| ermTRAb: 5’AAA ATA TGC TCG TGG CAC3’ | ||
| ermA/TRSb: 3’TCA GGA AAA GGA CAT TTT ACC5’ |
Dispersal 110 Coagulase negative staphylococci isolated from hospitalized patients
| Beast hospital | Toohid hospital | |||
|---|---|---|---|---|
| care unit ward | infectious ward | care unit ward | infectious ward | |
| 13(11.8%) | 2(1.8%) | 30(27.3%) | 33(30%) | |
| 7 (6.4%) | 1 (0.9) | 15(13.6%) | 9 (8.2%) | |
| 20(18.2%) | 3(2.7%) | 45(40.9%) | 42(38.2%) | |
Antimicrobial susceptibility of CNS isolates
| Beast hospital | Toohid hospital | |||
|---|---|---|---|---|
| Resistant | Susceptible | Resistant | Susceptible | |
| 13(11.8 %) | 10(9.1%) | 51(46.4%) | 36(32.7%) | |
| 7(6.4%) | 16(14.5%) | 41(37.3%) | 46(41.8%) | |
| 6 (12.5%) | - | 29(60.4%) | - | |
cMLSB: constitutive resistance (Clindamycin resistance, erythromycin resistance).
Figure 3Genomic DNA fingerprinting patterns from strains CNS generated by ERIC-PCR
Figure 4Dendrograms of genomic similarity of 110 CNS strains in Sanandaj hospitals
Clustering and similarity of CNS isolates and Number of strains in each cluster
| Clusters | Dendrogram similarityin clusters | Number of strainsin each cluster | ||
|---|---|---|---|---|
| Toohid.H | Besat.H | Total | ||
| 42% | 7 | 3 | ||
| 39% | 8 | 0 | ||
| 49% | 4 | 7 | 11 | |
| 48% | 2 | 2 | ||
| 50% | 5 | 3 | ||
| 38% | 3 | 3 | ||
| 45% | 7 | 2 | ||
| 37% | 2 | 0 | ||
| 44% | 6 | 2 | ||
| 33% | 9 | 0 | ||
| 28% | 8 | 1 | ||
| 29 % | 9 | 0 | ||
| 27% | 13 | 0 | ||
| 34% | 4 | 0 | ||
Distribution of genetic and characterization of 14 cluster of 110 CNS clinical isolates
| Cluster | number of Profile | percentage of strain | MRCNS | ERCNS | iMLS B phenotypes | Multiplex PCR erm genes | hospital |
|---|---|---|---|---|---|---|---|
| 4 | 9.1% | 4.5% | 3.6% | 2.1% | 2.1% | T. H 6.4% | |
| (10) | 5 | 4 | 1 | 1 | B. H 2.7% | ||
| 7 | 7.3% | 2.7% | 1.8% | 0 | 0 | T. H 7.3% | |
| (8) | 3 | 2 | B. H 0.0% | ||||
| 11 | 10% | 3.6% | 0.0% | 0 | 0 | T. H 3.6% | |
| (11) | 4 | 0 | B. H 6.4% | ||||
| 4 | 3.6% | 3.6% | 0.0% | 0 | 0 | T. H 1.8% | |
| (4) | 4 | 0 | B. H 1.8% | ||||
| 7 | 7.3% | 5.5% | 4.5% | 2.1% | 2.1% | T. H 4.5% | |
| (8) | 6 | 5 | 1 | 1 | B. H 2.7% | ||
| 6 | 5.5% | 4.5% | 4.5% | 2.1% | 2.1% | T. H 2.7% | |
| (6) | 5 | 5 | 1 | 1 | B. H 2.7% | ||
| 8 | 8.2% | 6.4% | 5.5% | 0 | 0 | T. H 6.4% | |
| (9) | 7 | 6 | B. H 1.8 % | ||||
| 2 | 1.7% | 1.8% | 1.8% | 0 | 0 | T. H 1.8 % | |
| (2) | 2 | 2 | B. H 0.0% | ||||
| 7 | 7.3% | 3.6% | 1.8% | 0 | 0 | T. H 5.5% | |
| (8) | 4 | 2 | B. H 1.8% | ||||
| 7 | 8.2% | 4.5% | 4.5% | 0 | 0 | T. H 8.2% | |
| (9) | 5 | 5 | B. H 0.0% | ||||
| 6 | 8.2% | 6.4% | 5.5% | 0 | 0 | T. H 7.3% | |
| (9) | 7 | 6 | B. H 0.9 % | ||||
| 5 | 8.2% | 2.7% | 4.5% | 2.1% | 0 | T. H 8.2% | |
| (9) | 3 | 5 | 1 | B. H 0.0 % | |||
| 12 | 11.8% | 5.5% | 3.6% | 2.1% | 2.1% | T. H 11.8% | |
| (13) | 6 | 4 | 1 | 1 | B. H 0.0 % | ||
| 4 | 3.6% | 2.7% | 1.8% | 0 | 0 | T. H 3.6% | |
| (4) | 3 | 2 | B. H 0.0 % | ||||
| 90 | 100% | 58.2% | 43.6% | 10.4% | 8.2% | T. H 79.1% | |
| 110 | 64 | 48 | 5 | 4 | B. H 20.9 % |
T. H: Toohid hospital; B. H: Beast hospital; CNS: Coagulase negative staphylococci; MRCNS: methicillin -resistant CNS; ERCNS: resistant to erythromycin CNS.